Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > Dr Sam Wiseman, University of British Columbia

<< Previous

Bullboard Posts

Next >>

Post by steadfaston Mar 30, 2021 6:52pm

265 Views

Post# 32911093

Dr Sam Wiseman, University of British Columbia

I would encourage you to read Feb 3, 2021 NR
He is Co-Investigator of SVA's Cell POuch Hypothyroid, will present preclinical date.
It would be great if you went back to SVA Nr's and post the dates of prior NR's re
Dr Wiseman and Thyroid. This has been ongoing for a # of years. Hopefully, one
day SVA can get into Clinical Trials with Dr Wiseman. Everything seems to move at a
snail's pace.The positive is the Cell Pouch has another disease to cure and a plus
that Dr Wiseman is presenting..

<< Previous

Bullboard Posts

Next >>

Nine Mile Metals completes acquisition of 3 properties